Deutsche Bank
SKYE icon

Deutsche Bank’s Skye Bioscience SKYE Stock Holding History

Deutsche Bank’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,922
Closed -$23.3K – 3749
2025
Q3 		$23.3K Hold
5,922
– – ﹤0.01% 3496
2025
Q2 		$24.8K Sell
5,922
-38,365
-87% -$79.4K ﹤0.01% 3474
2025
Q1 		$70.4K Buy
44,287
+3,452
+8% +$9.42K ﹤0.01% 3303
2024
Q4 		$116K Buy
40,835
+32,054
+365% +$134K ﹤0.01% 3255
2024
Q3 		$34.3K Hold
8,781
– – ﹤0.01% 3413
2024
Q2 		$70.3K Buy
+8,781
New +$104K ﹤0.01% 3242

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Deutsche Bank's SKYE Position: Q4 2025 in Review

Deutsche Bank sold out of Skye Bioscience (SKYE) in Q4 2025, closing a stake of 5,922 shares — an estimated $23.3K sold.

Deutsche Bank first reported a position in SKYE in Q2 2024 and held it in 6 quarters. The position peaked at $116K in Q4 2024. 50 funds tracked by Wall St. Rank hold SKYE as of Q4 2025.

  • Deutsche Bank reported no remaining Skye Bioscience position as of Q4 2025 after selling out during the quarter.
  • Deutsche Bank sold 5,922 Skye Bioscience shares in Q4 2025, an estimated $23.3K.
  • Deutsche Bank first reported a position in Skye Bioscience in Q2 2024 and held it in 6 quarters.
  • Deutsche Bank's Skye Bioscience position peaked at $116K in Q4 2024.
  • 50 funds tracked by Wall St. Rank held Skye Bioscience as of Q4 2025.

Based on Deutsche Bank's 13F filing for Q4 2025, filed 11 Feb 2026.